About
Dr. Kunal Joshi is skilled in innovative medicine commercialization & scale-up with a unique fusion of medicine, business management, and IPR Law.
With over a decade of experience in India and South Asia, Dr. Kunal has made a significant impact in diverse domains within the healthcare industry. Currently he is heading Marketing & Commercial Launch Excellence of Innovative Oncology Therapies like Cell & Gene Therapy (CAR T-cell) & Immuno-Oncology at Dr Reddy’s Laboratories where he is following his passion of accelerated access to innovative healthcare because “Good Health Can’t Wait”.
In the past he has played a pivotal role in steering the commercial launch excellence of advanced medicines, like CAR T-cell therapy, stem cell therapy, cell therapy biocosmetics, biologics, cardio-renal-diabetes and neuroscience therapies across India and the APAC. Throughout his career, he has worked at globally renowned companies such as Johnson & Johnson, AstraZeneca, Stempeutics (Manipal Group) and early stage healthcare startups like Immuneel, successfully serving in sales, marketing, business development, healthcare policy & access, and digital transformation roles.
In recognition of his unwavering dedication and remarkable achievements in the realm of Healthcare he was bestowed with the prestigious Business World Healthcare 40 under 40 Award in 2023. Dr. Kunal remains at the forefront of catalyzing positive change in the healthcare landscape in India and the World.see more
Experience
Tell us about your professional experience
Education
Where did you complete your basic education from?
Skills
Healthcare
Sales
Marketing
Medical
Business / Growth Strategy
Accomplishments
Languages
English
Gujarati
Hindi
Kannada
Marathi
Telugu
About
Dr. Kunal Joshi is skilled in innovative medicine commercialization & scale-up with a unique fusion of medicine, business management, and IPR Law.
With over a decade of experience in India and South Asia, Dr. Kunal has made a significant impact in diverse domains within the healthcare industry. Currently he is heading Marketing & Commercial Launch Excellence of Innovative Oncology Therapies like Cell & Gene Therapy (CAR T-cell) & Immuno-Oncology at Dr Reddy’s Laboratories where he is following his passion of accelerated access to innovative healthcare because “Good Health Can’t Wait”.
In the past he has played a pivotal role in steering the commercial launch excellence of advanced medicines, like CAR T-cell therapy, stem cell therapy, cell therapy biocosmetics, biologics, cardio-renal-diabetes and neuroscience therapies across India and the APAC. Throughout his career, he has worked at globally renowned companies such as Johnson & Johnson, AstraZeneca, Stempeutics (Manipal Group) and early stage healthcare startups like Immuneel, successfully serving in sales, marketing, business development, healthcare policy & access, and digital transformation roles.
In recognition of his unwavering dedication and remarkable achievements in the realm of Healthcare he was bestowed with the prestigious Business World Healthcare 40 under 40 Award in 2023. Dr. Kunal remains at the forefront of catalyzing positive change in the healthcare landscape in India and the World.see more
Reviews